series-c-plus
Stage
2
Investors
About
Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company developing antibody-based cancer therapies focused on pediatric oncology and rare cancers.
Explore y-mabs's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.